Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment
Crossref DOI link: https://doi.org/10.1007/s40262-023-01236-4
Published Online: 2023-03-13
Published Print: 2023-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Agersnap, Mikkel Askjær http://orcid.org/0000-0002-5827-5870
Sonne, Kim
Knudsen, Kim Mark
Sulowicz, Wladyslaw
Text and Data Mining valid from 2023-03-13
Version of Record valid from 2023-03-13
Article History
First Online: 13 March 2023